- Home
- Equipment
- usa maryland
- blood pressure
Show results for
Refine by
Blood Pressure Equipment Supplied In Usa Maryland
5 equipment items found
Manufactured by:Creatv MicroTech, Inc. based inRockville, MARYLAND (USA)
Personalized Cancer Therapy and Disease Monitoring: “Liquid biopsy” using circulating tumor cells (CTCs) is potentially a minimally invasive alternative to traditional tissue biopsy to determine cancer therapy. Enumeration of CTCs may be used to indicate prognosis and to monitor treatment. Isolation of CTCs by size exclusion is a widely researched technique to collect CTCs from ...
Manufactured by:Otsuka America Pharmaceutical, Inc based inPrinceton, NEW JERSEY (USA)
After it is swallowed, ABILIFY MYCITE® (aripiprazole tablets with sensor) sends a tiny signal to a wearable Bluetooth®* patch that connects with your smartphone, allowing you to see your daily data all in one ...
Manufactured by:Aidar Health based inBaltimore, MARYLAND (USA)
MouthLab Mobile Monitoring System makes precision medicine a reality by rapidly gathering, and efficiently analyzing a large amount of clinically relevant subjective and objective information in real-time. It's as simple to use as a toothbrush yet comprehensive enough to provide a daily snapshot of your overall health, enabling early detection of disease progression and timely ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Unituxin is a GD2-binding monoclonal antibody indicated, in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2 (IL-2), and 13-cis-retinoic acid (RA), for the treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to prior first-line multiagent, multimodality ...